| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Edwards Lifesciences Corporation (EW) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. EW is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 215.9K | $18.54M | - | |
| VP | 98.6K | $8.47M | -23,145 | |
| CFO | 46.7K | $4.01M | - | |
| VP | 44.3K | $3.81M | - | |
| VP | 40.4K | $3.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2025 | Markowitz Wayne | Gm &SVP, Surgical | Sell | 268 | $75.08 | $20,120.85 | -2.8% | +5.6% | +10.3% | |
| May 5, 2025 | Zovighian Bernard J55 | CEO | Sale+OE | 5,980 | $74.91 | $447,976.75 | -9.3% | +6.6% | +10.4% | |
| Apr 14, 2025 | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sale+OE | 9,500 | $69.81 | $663,195.95 | -16.8% | +12.0% | +11.4% | |
| Apr 8, 2025 | Lippis Daniel J.62 | Cvp, Japac | Sale+OE | 300 | $70.61 | $21,183.00 | -1.3% | +14.3% | +21.8% | |
| Mar 26, 2025 | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sale+OE | 11,250 | $70.87 | $797,267.25 | -27.0% | +6.7% | +15.5% | |
| Mar 13, 2025 | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sale+OE | 9,500 | $67.96 | $645,623.80 | -16.8% | +11.1% | +20.4% | |
| Mar 10, 2025 | Zovighian Bernard J55 | CEO | Sale+OE | 6,164 | $69.51 | $428,447.93 | -9.4% | +11.4% | +25.2% | |
| Mar 10, 2025 | Lippis Daniel J.62 | Cvp, Japac | Sale+OE | 400 | $69.48 | $27,792.00 | -1.7% | +11.4% | +25.2% | |
| Feb 28, 2025 | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sale+OE | 11,250 | $70.78 | $796,326.99 | -14.1% | +8.5% | +20.7% | |
| Feb 14, 2025 | Loranger Steven R | Director | Sale+OE | 5,739 | $76.42 | $438,575.53 | -8.7% | +0.9% | -0.4% |